Phase II Study Assessing Safety and Preliminary Efficacy of High Dose Intravenous Ascorbic Acid in Patients with TET2 Mutant Clonal Cytopenias von Xie, Zhuoer, McCullough, Kristen, Lasho, Terra L, Fernandez, Jenna A., Finke, Christy M, Amundson, Michelle Renee, LaPlant, Betsy, Mangaokar, Abhishek, Gangat, Naseema, Reichard, Kaaren K., Elliott, Michelle Ann, Witzig, Thomas E., Patnaik, Mrinal M.

Volltext